Conference Coverage

An enlightened approach to weight loss using liraglutide


 

AT OBESITY WEEK 2016

This analysis and the clinical trials on which it was based were sponsored by Novo Nordisk, which markets liraglutide under the brand names Saxenda and Voctoza. The presenter reported receiving research grants from and serving as a consultant to Novo Nordisk and other pharmaceutical companies.

Pages

Recommended Reading

Experts endorse metabolic surgery for diabetes intervention
Type 2 Diabetes ICYMI
Pioglitazone safe and effective for steatohepatitis in T2DM
Type 2 Diabetes ICYMI
Benefits of lifestyle intervention only brief in some patients with type 2 diabetes
Type 2 Diabetes ICYMI
Bariatric surgery good deal for diabetes, but…
Type 2 Diabetes ICYMI
Bariatric Surgery Good Deal for Diabetes, but …
Type 2 Diabetes ICYMI
Benefits of Lifestyle Intervention Only Brief in Some T2DM Patients
Type 2 Diabetes ICYMI
Metabolic health declining among the obese, despite improvements in BP and lipids
Type 2 Diabetes ICYMI
Metabolic Health Declining Among the Obese, Despite Improvements in BP and Lipids
Type 2 Diabetes ICYMI
Rethinking diabetes nutrition: No more carb mixes?
Type 2 Diabetes ICYMI
Drug-induced weight gain: Rethinking our choices
Type 2 Diabetes ICYMI